Martingale Asset Management L P lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 22.8% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 255,268 shares of the healthcare conglomerate’s stock after selling 75,366 shares during the period. UnitedHealth Group accounts for approximately 0.7% of Martingale Asset Management L P’s portfolio, making the stock its 15th largest holding. Martingale Asset Management L P’s holdings in UnitedHealth Group were worth $47,333,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Marshall Wace LLP increased its stake in UnitedHealth Group by 441.4% in the second quarter. Marshall Wace LLP now owns 13,935 shares of the healthcare conglomerate’s stock valued at $2,578,000 after acquiring an additional 11,361 shares during the last quarter. Schwab Charles Investment Management Inc. increased its stake in UnitedHealth Group by 5.3% in the second quarter. Schwab Charles Investment Management Inc. now owns 3,656,975 shares of the healthcare conglomerate’s stock valued at $678,077,000 after acquiring an additional 183,401 shares during the last quarter. American Century Companies Inc. increased its stake in UnitedHealth Group by 16.9% in the second quarter. American Century Companies Inc. now owns 4,703,113 shares of the healthcare conglomerate’s stock valued at $872,051,000 after acquiring an additional 681,111 shares during the last quarter. Essex Financial Services Inc. increased its stake in UnitedHealth Group by 12.3% in the second quarter. Essex Financial Services Inc. now owns 8,846 shares of the healthcare conglomerate’s stock valued at $1,640,000 after acquiring an additional 967 shares during the last quarter. Finally, Factory Mutual Insurance Co. increased its stake in UnitedHealth Group by 20.9% in the second quarter. Factory Mutual Insurance Co. now owns 416,600 shares of the healthcare conglomerate’s stock valued at $77,245,000 after acquiring an additional 72,000 shares during the last quarter. Institutional investors own 86.00% of the company’s stock.

Shares of UnitedHealth Group Incorporated (UNH) opened at $211.71 on Wednesday. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.52. UnitedHealth Group Incorporated has a 1-year low of $148.56 and a 1-year high of $213.93. The company has a market cap of $204,541.08, a PE ratio of 21.99, a price-to-earnings-growth ratio of 1.57 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.57 by $0.09. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The business had revenue of $50.32 billion during the quarter, compared to analyst estimates of $50.38 billion. During the same period last year, the business posted $2.17 earnings per share. UnitedHealth Group’s quarterly revenue was up 8.7% compared to the same quarter last year. equities analysts anticipate that UnitedHealth Group Incorporated will post 9.99 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Friday, December 1st will be issued a $0.75 dividend. The ex-dividend date is Thursday, November 30th. This represents a $3.00 annualized dividend and a yield of 1.42%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 33.26%.

UNH has been the topic of a number of research analyst reports. Royal Bank Of Canada reissued a “buy” rating and issued a $212.00 target price on shares of UnitedHealth Group in a research note on Thursday, July 20th. BidaskClub cut UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, July 19th. Mizuho set a $235.00 target price on UnitedHealth Group and gave the company a “buy” rating in a research note on Tuesday, July 18th. Citigroup Inc. increased their target price on UnitedHealth Group from $195.00 to $213.00 and gave the company a “buy” rating in a research note on Wednesday, July 19th. Finally, Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $215.00 target price on the stock in a research note on Tuesday, August 1st. Three investment analysts have rated the stock with a hold rating and twenty-four have assigned a buy rating to the company. The company has an average rating of “Buy” and a consensus target price of $216.65.

ILLEGAL ACTIVITY NOTICE: “UnitedHealth Group Incorporated (UNH) Position Lessened by Martingale Asset Management L P” was originally reported by Watch List News and is the property of of Watch List News. If you are viewing this article on another website, it was copied illegally and republished in violation of U.S. & international trademark & copyright laws. The legal version of this article can be accessed at https://www.watchlistnews.com/unitedhealth-group-incorporated-unh-position-lessened-by-martingale-asset-management-l-p/1703945.html.

In other UnitedHealth Group news, insider Thomas E. Roos sold 975 shares of the firm’s stock in a transaction dated Thursday, October 19th. The shares were sold at an average price of $205.47, for a total value of $200,333.25. Following the completion of the sale, the insider now directly owns 24,630 shares in the company, valued at $5,060,726.10. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Richard T. Burke sold 15,000 shares of the firm’s stock in a transaction dated Monday, August 21st. The stock was sold at an average price of $191.71, for a total transaction of $2,875,650.00. Following the completion of the sale, the director now owns 1,818,898 shares of the company’s stock, valued at $348,700,935.58. The disclosure for this sale can be found here. Insiders sold 72,149 shares of company stock valued at $14,212,342 over the last 90 days. 0.89% of the stock is currently owned by company insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.